Compositions and methods for detecting Noonan syndrome
Patent
·
OSTI ID:1068839
- New York, NY
- Rome, IT
- Walnut Creek, CA
Diagnostic and therapeutic applications for Noonan Syndrome are described. The diagnostic and therapeutic applications are based on certain mutations in a RAS-specific guanine nucleotide exchange factor gene SOS1 or its expression product. The diagnostic and therapeutic applications are also based on certain mutations in a serine/threonine protein kinase gene RAF1 or its expression product thereof. Also described are nucleotide sequences, amino acid sequences, probes, and primers related to RAF1 or SOS1, and variants thereof, as well as host cells expressing such variants.
- Research Organization:
- Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC52-07NA27344
- Assignee:
- Mount Sinai School of Medicine (New York, NY); The Regents of the University of California (Oakland, CA)
- Patent Number(s):
- 8,221,979
- Application Number:
- 12/443,752
- OSTI ID:
- 1068839
- Country of Publication:
- United States
- Language:
- English
Similar Records
Noonan syndrome patient-specific induced cardiomyocyte model carrying SOS1 gene variant c.1654A>G
Structural basis of the atypical activation mechanism of KRASV14I
Gain-of-function SOS1 mutations cause a distinctive form of noonansyndrome
Journal Article
·
Mon Mar 15 00:00:00 EDT 2021
· Experimental Cell Research
·
OSTI ID:1068839
+5 more
Structural basis of the atypical activation mechanism of KRASV14I
Journal Article
·
Wed Jul 24 00:00:00 EDT 2019
· Journal of Biological Chemistry
·
OSTI ID:1068839
+5 more
Gain-of-function SOS1 mutations cause a distinctive form of noonansyndrome
Journal Article
·
Fri Sep 01 00:00:00 EDT 2006
· Nature Genetics
·
OSTI ID:1068839
+22 more